Hänseler in the media

Qualifyze Gold Certificate for Hänseler Swiss Pharma

June 2024


 

Hänseler Swiss Pharma receives the coveted Gold Certificate in the Quality Compliance Rating of Qualifyze GmbH. The Quality Compliance Score evaluates suppliers and manufacturers on three fundamental aspects: Audit Findings, CAPA Behavior and Audit Chapter Scoring. With this Gold Certificate, Hänseler Swiss Pharma once again distinguishes itself for high quality standards and reliable compliance.

Expansion to 2-shift operation at Hänseler AG

February 2024



Good news from the Herisau economic area. The exceptionally good order situation means that Hänseler AG is increasing its production capacities with immediate effect and is now introducing two-shift operation instead of the previous one-shift operation. "This operational decision is of great importance for Hänseler AG and the Herisau site and is in line with our growth strategy," says Dr. Dominik Hauser, CEO of Hänseler AG in herisau.

Pharma Tech Outlook Award for Hänseler Swiss Pharma

October 2023



Hänseler Swiss Pharma to be in the annual listing of 5 companies in Switzerland that provide exceptional services for enhancing operational efficiency and impact the Pharma Industry. Have a look at Hänseler Swiss Pharma's cover story and read about how we realize your product ideas to market success.

Groundbreaking ceremony for the new Hänseler AG building

August 2023



A significant milestone was reached on August 22, 2023 when Hänseler AG held the groundbreaking ceremony for the construction of its new production building. The project represents a further investment by Hänseler Swiss Pharma in the infrastructure on its Herisau site. The company is aiming to strengthen its wellestablished position on the Swiss market whilst enabling growth beyond the country’s borders.

People buy because they have confidence

März 2022

From the Appenzell region to the world: Swiss Hänseler AG, headquartered in Herisau, is at home in the Swiss mountains. But the pharmaceutical production and trading company is increasingly looking abroad, with the aim of growing internationally. After two years of the coronavirus with ups and downs, the company is now set to return to calmer waters – with further products for health and well-being. Interview with Dr. Dominik Hauser, Managing Director of Hänseler AG in "Wirtschaftsforum"

Swiss supply in time of trouble

April 23, 2021

The coronavirus crisis has undoubtedly turned the world on its head, but for Hänseler AG, a leading Swiss manufacturer and supplier to the pharmaceutical sector, cool and calm efficiency is the order of the day as it maintains a flow of disinfectants, OTC products and raw materials for pharmacies and hospitals. While enjoying a boom in demand for natural health products, the company is also looking to bolster its international standing with herbal OTC products in women’s health, tinctures and plant based extracts. Andy Probert reports;

Swissness in times of Corona - Hänseler AG

April 24, 2020

Everything is running at full speed at Hänseler AG right now. As a manufacturer of pharmaceutical raw materials, the Swiss company is an important supplier to disinfectant producers. Due to the corona crisis, demand has now exploded.

Switzerland Global Enterprise - MEMBER OF THE MONTH DECEMBER 2019

Nov 28 2019 16:12
Susanne Rieder Hauert, Switzerland Global Enterprise

Hänseler AG is a Swiss production and trading company in the pharmaceutical sector. Its three main pillars are the trade and further processing of pharmaceutical raw materials, the production and distribution of over-the-counter medicines, and the production and packaging on behalf of partner companies. In this interview, Dr. Dominik Hauser, CEO of Hänseler AG, tells us what he is particularly proud of and how the company will be successful in exports in the future.